Abiopharma

(10% Negative) KAMADA (KMDA) Announces Regulatory Update (Form 6-K)

(10% Negative) Jazz Pharmaceuticals plc (JAZZ) Announces Business Combination

(10% Negative) INSMED INCORPORATED (INSM) Reports Q4 2022 Financial Results

(99% Neutral) Denali Therapeutics Inc. (DNLI) Files Form 8-K

(10% Negative) Instil Bio, Inc. (TIL) Announces Delay in patients Trials for cancer Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(30% Negative) PTC THERAPEUTICS, INC. (PTCT) Announces Delay in first Trials for several European countries as well as Australia Due to Patient Enrollment Issues, Regulatory Process, Safety Review

(99% Neutral) ChemoCentryx, Inc. (CCXI) Announces Business Combination

(10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K)

(75% Positive) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Announces Clinical Development Update (Form 6-K)

(70% Positive) Caribou Biosciences, Inc. (CRBU) Announces Enrollment Update for reported Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment